Uso de la lisofosfatidilcolina, de sus composiciones y de sus formas farmacéuticas en la elaboración de un medicamento para la prevención, tratamiento y/o alivio de una infección microbiana, y en particular de las infecciones producidas por cepas de la es
-
November 4, 2022 (v1)PublicationUploaded on: March 24, 2023
-
December 11, 2023 (v1)Publication
Método de identificación de aislados bacterianos resistentes a las combinaciones de antibiótico β-lactámico con inhibidores de β-lactamasa, capaces de hidrolizar el anillo β- lactámico de una combinación de un antibiótico β-lactámico con un inhibidores de β- lactamasa (BL/IBL), método para determinar la capacidad de desarrollo de resistencia de...
Uploaded on: December 13, 2023 -
January 16, 2019 (v1)Publication
Enterobacteriaceae cause different types of community- and hospital-acquired infections. Moreover, the spread of multidrug-resistant Enterobacteriaceae is a public health problem and the World Health Organization pointed them among the pathogens in which the search of new antibiotics is critical. The objective of this study was to analyze the...
Uploaded on: December 5, 2022 -
May 20, 2021 (v1)Publication
The stimulation of the immune response to prevent the progression of an infection may be an adjuvant to antimicrobial treatment. Here, we aimed to evaluate the efficacy of lysophosphatidylcholine (LPC) treatment in combination with colistin in murine experimental models of severe infections by Acinetobacter baumannii. We used the A. baumannii...
Uploaded on: March 25, 2023 -
November 22, 2017 (v1)Publication
Acinetobacter baumannii (American Type Culture Collection strain 19606) acquires mutations in the pmrB gene during the in vitro development of resistance to colistin. The colistin-resistant strain has lower affinity for colistin, reduced in vivo fitness (competition index, .016), and decreased virulence, both in terms of mortality (0% lethal...
Uploaded on: December 4, 2022 -
May 10, 2021 (v1)Publication
Adhesion is an initial and important step in Acinetobacter baumannii causing infections. However, the exact molecular mechanism of such a step between A. baumannii and the host cells remains unclear. Here, we demonstrated that the phosphorylcholine (ChoP)-containing outer membrane protein of A. baumannii binds to A549 cells through...
Uploaded on: December 4, 2022 -
May 9, 2023 (v1)Publication
In 2019, the biggest listeriosis outbreak by Listeria monocytogenes (Lm) in the South of Spain was reported, resulting in the death of three patients from 207 confirmed cases. One strain, belonging to clonal complex 388 (Lm CC388), has been isolated. We aimed to determine the Lm CC388 virulence in comparison with other highly virulent clones...
Uploaded on: May 11, 2023 -
July 5, 2021 (v1)Publication
The development of new strategic therapies for multidrug-resistant bacteria, like the use of non-antimicrobial approaches and/or drugs repurposed to be used as monotherapies or in combination with clinically relevant antibiotics, has become urgent. A therapeutic alternative for infections by multidrug-resistant Gram-negative bacilli (MDR-GNB)...
Uploaded on: March 25, 2023 -
May 25, 2018 (v1)Publication
Acinetobacter baumannii is a significant human pathogen associated with hospital-acquired infections. While adhesion, an initial and important step in A. baumannii infection, is well characterized, the intracellular trafficking of this pathogen inside host cells remains poorly studied. Here, we demonstrate that transcription factor EB (TFEB) is...
Uploaded on: March 27, 2023 -
November 4, 2022 (v1)Publication
Repurposing drugs provides a new approach to the fight against multidrug-resistant (MDR) bacteria. We have reported that three major tamoxifen metabolites, N-desmethyltamoxifen (DTAM), 4-hydroxytamoxifen (HTAM), and endoxifen (ENDX), presented bactericidal activity against Acinetobacter baumannii and Escherichia coli. Here, we aimed to analyze...
Uploaded on: December 5, 2022 -
October 6, 2022 (v1)Publication
Previously, we identified that a cyclic hexapeptide AOA-2 inhibited the interaction of Gram-negative bacilli (GNB) like Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli to host cells thereby preventing the development of infection in vitro and in a murine sepsis peritoneal model. In this work, we aimed to evaluate in...
Uploaded on: March 24, 2023 -
May 14, 2020 (v1)Publication
Preventing the adhesion of pathogens to host cells provides an innovative approach to tackling multidrug-resistant bacteria. In this regard, the identifcation of outer membrane protein A (OmpA) as a key bacterial virulence factor has been a major breakthrough. The use of virtual screening helped us to identify a cyclic hexapeptide AOA-2 that...
Uploaded on: March 27, 2023 -
July 7, 2023 (v1)Publication
Introduction: Haematopoietic stem cell transplantation (HSCT) is a life-saving treatment for a number of haematological diseases. Graft versus host disease (GVHD) is its main complication and hampers survival. There is strong evidence that intestinal microbiota diversity of the recipient may increase the risk of GVHD worsening survival....
Uploaded on: July 8, 2023 -
November 30, 2022 (v1)Publication
introducción: La estimulación de la respuesta inmunitaria podría ser adyuvante al tratamiento antimi- crobiano. En este estudio, hemos evaluado el impacto de la modificación de la respuesta inmunitaria por la lisofosfatidilcolina (LPC), combinada con imipenem ó ceftazidima, en modelos murinos de sepsis peritoneal (SP) y de neumonía por...
Uploaded on: December 4, 2022 -
August 26, 2022 (v1)Publication
Three-dimensional (3D) engineered cardiovascular tissues have shown great promise to replace damaged structures. Specifically, tissue engineering vascular grafts (TEVG) have the potential to replace biological and synthetic grafts. We aimed to design an in-vitro patient-specific patch based on a hybrid 3D print combined with vascular smooth...
Uploaded on: March 24, 2023 -
October 2, 2020 (v1)Publication
Colistin is among the few antibiotics effective against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates. However, in the last few years, colistin-resistant A. baumannii and K. pneumoniae strains have emerged. Therefore, combination therapies, between colistin and other old drugs, restoring the activity of...
Uploaded on: March 26, 2023 -
April 29, 2020 (v1)Publication
Background: S. pneumoniae is the leading cause of community-acquired pneumonia in the solid organ transplant recipient (SOTR); nevertheless, the prevalence of colonization and of the colonizing/infecting serotypes has not been studied in this population. In this context, the aim of the present study was to describe the rate, characteristics,...
Uploaded on: March 27, 2023